Thomas Saunders and John Serio, partners in the Boston office, will be presenting Freedom to Operate Assessments in Biotechnology: Analysis, Opinions and More at the upcoming American Conference Institute seminar.
The presentation will cover:
- Knowing when a freedom to operate analysis is necessary
- Guaranteeing the right to commercialize the IP at issue without infringing the claims of a third party
- identifying and analyzing potential blocking patents
- monitoring activity in pending third party applications
- assessing infringement risks in biotech
- considering indirect infringement issues
- including un-issued patents and predated priority dates, common with biotechnology
- evaluating patent issues outside the U.S.
- Accounting for the complexity of increasingly overlapping patents
- determining claim scope
- finding out what is pending
- checking on ongoing prosecution to predict what may issue
- Effectively conducting the more elaborate search necessary for biologic compounds
- defining and refining the topic
- finding and mining useful tools and sources of information
- managing the intricacies of sequence searching
- Deciding if an FTO opinion is necessary
- evaluating the strength of a possible opinion
- understanding the complexities of privilege and discovery issues relative to opinions
- Analyzing current case law that can affect your FTO analysis
- the impact of the 271(e)(1) safe harbor
For more information, or to register, please visit the event's website.